HIV/antiretroviral therapy–related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma
Joaquim Peraire(Instituto de Salud Carlos III), Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Verònica Alba, Sara Ferrando‐Martínez(National Institutes of Health), Xavier Escoté(Technological Center of Nutrition and Health), Joan Vendrell(Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas), Víctor Asensi(Baylor College of Medicine), Mireia Arnedo(Escuela Nacional de Sanidad), Peré Domingo(Hospital de Sant Pau), Consuelo Viladés(Hospital Universitario Fundación Jiménez Díaz), Estebán Martínez(Instituto de Salud Carlos III), Sergio Veloso(Hospital Terrassa), Miguel López-Dupla, M. Leal(Instituto de Biomedicina de Sevilla), M-I Inza(Institut de Recerca Biomèdica Catalunya Sud), JM Gatell(Hospital Clínic de Barcelona), Eulalia Valle-Garay, Gràcia Mateo(Evidence (Italy)), Raúl Beltrán‐Debón(Institut de Recerca Biomèdica Catalunya Sud)
Cited by 12
Related Papers
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
|New England Journal of Medicine|2023|476
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
|Mucosal Immunology|2014|332
CMV and Immunosenescence: from basics to clinics
|Immunity & Ageing|2012|182